WARREN, N.J., Nov. 7, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the quarter and nine months ended September 30, 2016.
Third Quarter 2016 Financial Results:
Revenue for the quarter ended September 30, 2016 was $1.9 million compared with $1.5 million for the third quarter of 2015, and $1.8 million for the second quarter of 2016. The increase in third quarter revenue year-over-year resulted from an increase in the number of Atlas® instruments placed with commercial customers and increased commercial utilization of the instruments. As of September 30, 2016, the Company had 49 instruments placed with customers under commercial agreements compared to 46 instruments as of June 30, 2016.
